Variant report
Variant | esv20938 |
---|---|
Chromosome Location | chr2:167447880-167462030 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12467716 | chr2:167448000-167448001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541647937 | chr2:167448019-167448020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs79585159 | chr2:167448082-167448083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547068014 | chr2:167448114-167448115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1374595 | chr2:167448131-167448132 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs142889904 | chr2:167448172-167448173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs77172799 | chr2:167448174-167448175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529660442 | chr2:167448180-167448181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550465941 | chr2:167448181-167448182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543399845 | chr2:167448211-167448212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140020047 | chr2:167448241-167448242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552854183 | chr2:167448243-167448244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs566034594 | chr2:167448251-167448252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs563274699 | chr2:167448307-167448308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115583232 | chr2:167448312-167448313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201596167 | chr2:167448315-167448316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572664867 | chr2:167448323-167448324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143936560 | chr2:167448364-167448365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190695842 | chr2:167448385-167448386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181538234 | chr2:167448425-167448426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373545342 | chr2:167448465-167448466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556024181 | chr2:167448474-167448475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563026969 | chr2:167448485-167448486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530561995 | chr2:167448499-167448500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371646794 | chr2:167448575-167448576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs146387020 | chr2:167448595-167448596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564778225 | chr2:167448597-167448598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374963830 | chr2:167448626-167448627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7592457 | chr2:167448639-167448640 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs541074123 | chr2:167448649-167448650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562174164 | chr2:167448677-167448678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368164992 | chr2:167448679-167448680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560839726 | chr2:167448700-167448701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186976206 | chr2:167448704-167448705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549833108 | chr2:167448730-167448731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563947668 | chr2:167448731-167448732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532899399 | chr2:167448740-167448741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs539019688 | chr2:167448756-167448757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74334106 | chr2:167448768-167448769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528702694 | chr2:167448779-167448780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139742882 | chr2:167448789-167448790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372935272 | chr2:167448813-167448814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568497524 | chr2:167448825-167448826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs376335132 | chr2:167448832-167448833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs74787691 | chr2:167448875-167448876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140327696 | chr2:167448921-167448922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111680677 | chr2:167448929-167448930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs76169135 | chr2:167448942-167448943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs569605061 | chr2:167448950-167448951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7581664 | chr2:167448965-167448966 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Glioblastoma | 21080181 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Autism | 18414403 | CNVD |
Developmental delay | 21147756 | CNVD |
Prostate cancer | 16573809 | CNVD |
Epilepsy | 21204806 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neonatal seizures | 20384724 | CNVD |
severe myoclonic epilepsy of infancy | 18294202 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:167448000-167450800 | Enhancers | Muscle Satellite Cultured Cells | -- |
2 | chr2:167448200-167451000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr2:167448600-167449600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
4 | chr2:167448600-167449600 | Enhancers | Osteobl | bone |
5 | chr2:167448600-167449800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
6 | chr2:167448600-167449800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr2:167448600-167450600 | Enhancers | NH-A | brain |
8 | chr2:167449000-167450600 | Enhancers | NHLF | lung |
9 | chr2:167449800-167451000 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr2:167451000-167451400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |